Related Experiment Video
Updated: May 26, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Improving the outcomes: developing cancer therapeutics
1Charite - Universitaetsmedizin Berlin, Campus Virchow-Klinikum, Institut fuer Medizinische Immunologie, Augustenburger Platz 1, 13353 Berlin, Germany. nalan.utku@charite.de
Future Oncology (London, England)
|December 14, 2011
Summary
Developing new oncology therapeutics faces challenges, with low success rates and high costs. Improved research, preclinical models, and clinical trials, including biomarker use and combination therapies, are crucial for advancing cancer drug development.
Area of Science:
- Oncology
- Drug Development
- Cancer Biology
Background:
- Oncology therapeutics have a low market success rate compared to other drugs.
- High costs and attrition rates characterize cancer drug development.
- Current approaches necessitate innovation in research and development.
Purpose of the Study:
- To identify key areas for improving oncology research and development.
- To explore novel strategies for enhancing cancer therapeutic development.
- To address the challenges in bringing new cancer drugs to market.
Main Methods:
- Reviewing current oncology research and development paradigms.
- Evaluating the role of cancer biology in drug discovery.
- Assessing the utility of biomarkers, novel targets (e.g., cancer stem cells), and combination therapies.
- Examining improvements in preclinical models and clinical trial designs.
Main Results:
- Understanding cancer biology is fundamental for new therapeutic approaches.
- Biomarkers aid in early decision-making and patient selection but require validation.
- Targeting cancer stem cells and employing combination therapies show promise.
- Optimized preclinical models and clinical trials can accelerate development.
Conclusions:
- Innovative strategies in oncology research and development are essential.
- Integrating biomarkers, novel targets, and combination therapies can improve success rates.
- Enhancing preclinical and clinical trial methodologies is critical for faster and more effective cancer drug development.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...